OLIGOMERIX, INC.

Profile

Company Names

OLIGOMERIX, INC.

Addresses

2 WESTCHESTER PARK DRIVE, SUITE 208, WHITE PLAINS, NY 10604

3960 BROADWAY, SUITE 340D, NEW YORK, NY 10032

Phone Numbers

212-568-0365

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$2,915,568.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2024-11-25 
$75,000.00 
$650,000.00 
$575,000.00 
Debt 
2
2022-03-24 
$2,440,568.00 
$3,500,000.00 
$1,059,432.00 
Equity 
1
2015-04-03 
$400,000.00 
$3,000,000.00 
$2,600,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY 
 
BLUESTEIN 
DIRECTOR
OLIGOMERIX, INC.   |  TUSHY, INC.
DAVID 
 
DANTZKER 
DIRECTOR
NOVARAY MEDICAL, INC.   |  OLIGOMERIX, INC.   |  ORIGIN, INC.   |  ORIGIN LIFE SCIENCES, INC.
ELIOT 
 
DAVIDOWITZ 
DIRECTOR, EXECUTIVE OFFICER
OLIGOMERIX, INC.
DOUGLAS 
 
DURAND 
DIRECTOR
OLIGOMERIX, INC.
WILLIAM 
 
ERHARDT 
DIRECTOR, EXECUTIVE OFFICER
OLIGOMERIX, INC.
ROBERT 
 
FOERSTER 
EXECUTIVE OFFICER, DIRECTOR
OLIGOMERIX, INC.
ROBERT 
 
FORESTER 
EXECUTIVE OFFICER
OLIGOMERIX, INC.
VICTOR 
 
MICATI 
DIRECTOR
OLIGOMERIX, INC.   |  ORIGIN LIFE SCIENCES, INC.
JAMES 
 
MOE 
EXECUTIVE OFFICER, DIRECTOR
ANTE5, INC.   |  OLIGOMERIX, INC.
JACK 
 
PASINI 
DIRECTOR, EXECUTIVE OFFICER
OLIGOMERIX, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-12-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2024-11-25 
2022-03-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-24 
2015-04-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#